Publication | Closed Access

The potential DPP-4 inhibitors from Xiao-Ke-An improve the glucolipid metabolism via the activation of AKT/GSK-3β pathway

Molecular PharmacologyPotential Dpp-4 InhibitorsSignal TransductionAkt/gsk-3β PathwayBiochemistrySignaling PathwayMedicineNatural SciencesG Protein-coupled ReceptorReceptor Tyrosine KinaseGlucolipid MetabolismCellular BiochemistryMetabolic SignalingPharmacologyCell BiologyCell SignalingDrug Discovery